Theravance Biopharma Inc. (TBPH)

TBPH trades at $14.41, 15.3% above the near-term max pain of $12.5 expiring Oct 17, 2025 (13 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($12.5-$15), reflecting growing call interest at higher strikes. Key magnetic zone at 13 where 2 expirations converge.

Max pain for TBPH shows an upward trend from 12.5 to 15, suggesting bullish positioning in longer-dated options. The 18% spread signals divergent expectations across timeframes. Levels distributed around 14.41. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.